Current and Future Developments of Predictive Markers and Prognostic Testing in IBD
Making a Difference: Patient-Centered Ulcerative Colitis Care in the Era of JAK Inhibitors and S1P Modulators
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
Sophie M. Balzora, MD
Latonia Ward, M.Min
What is New in Anti -TNFs and Anti-Integrins?
Joel Pekow, MD, MPH
IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going
Matthew Ciorba, MD
Crohn’s & Colitis Congress 2022: A Look at Diet & Nutrition Therapies
Jennifer Caudle, DO
Maitreyi Raman , MD, MSc, FRCPC
Loading...
We’re glad to see you’re enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.